EDITION
  • English
  • 中文
  • Bahasa
  • eCommerce
Saturday, January 28, 2023
uLearnMoney Subscription Events
No Result
View All Result
Money Compass

EDITIONS:

Media and partner organizations:

cmc bmc ulearnmoney mylife mcm
  • HOME
  • NEWS
    • Global Market News
    • Local Market News
    • Corporate News
    • PLC News
  • SPECIAL FEATURE
  • COMPASS
    • Financial
    • Investment
    • Start Up
    • Capital
    • Infographics & Quotes
  • MONEY TUBE
  • LIFESTYLE
  • PR NEWSWIRE
Subscription Newsletter
Money Compass
  • HOME
  • NEWS
    • Global Market News
    • Local Market News
    • Corporate News
    • PLC News
  • SPECIAL FEATURE
  • COMPASS
    • Financial
    • Investment
    • Start Up
    • Capital
    • Infographics & Quotes
  • MONEY TUBE
  • LIFESTYLE
  • PR NEWSWIRE
No Result
View All Result
中文 Bahasa eCommerce
Money Compass

COVID-19: CanSino vaccine ready for bigger rollout to private market as booster shot

by moneycompass
November 10, 2021
in Current News
vaccine
Share on FacebookShare on WhatsApp

KUALA LUMPUR – Solution Group Bhd’s (SGB) wholly-owned subsidiary Solution Biologics Sdn Bhd (Solbio) is expecting approval to sell Convidecia vaccine on the private market and administer it as a booster shot soon, reported Bernama.

Solbio is the ASEAN manufacturing partner of CanSino Biologics Inc’s single-dose Convidecia vaccine for COVID-19.

SGB deputy group managing director Datuk Dr Mohd Nazlee Kamal said as soon as the company gets approval from the Ministry of Health (MOH), SGB will be expanding the vaccine distribution to the private market such as hospitals, clinics, the corporate and manufacturing sectors in Malaysia.

“We also hope to get the National Pharmaceutical Regulatory Agency (NPRA) approval for Convidecia to be used as a booster shot in November.

“Once it is approved, it will be an additional option for those who originally received a two-dose inactivated vaccine as the Jiangsu study shows that Convidecia is safe and highly efficacious as a booster,” he said in a filing with Bursa Malaysia on November 9.

Solbio has submitted data showing the efficacy of Convidecia vaccine as a booster shot to the NPRA, demonstrating that taking a Convidecia booster shot six months after the first dose showed an increase of at least eight times in antibody levels.

Mohd Nazlee said the technical working group from the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) recommends the use of different vaccines to boost vaccine efficacy as practised by other countries.

“We have more than enough capacity to supply both primary and booster doses to fulfill the market demand not just for Malaysia but also the ASEAN region,” he added.

Under an agreement with MOH, Solbio is supplying 3.5 million doses of Convidecia.

To date, Solbio has completed the delivery of 2.6 million doses of the COVID-19 vaccine.

Another 300,000 doses are arriving on November 12 and the balance of 600,000 doses to be delivered by December.

With the completion of the MOH contract, the sales from the private sector and the contribution from other business segments, SGB is expecting a turnover of approximately RM300 million with a profit margin of 10% to 15% for the financial year ending 2021.

 

Read more: A Look Into Malaysian Financial Habits and Their Long-Term Goals

Tags: ASEANCanSinoCovid-19Ministry of Health (MOH)
ShareSendShareSendTweetShare
Previous Post

ASEAN sectoral bodies releases ASEAN Taxonomy for Sustainable Finance – Version 1

Next Post

US$1.5 mil investment to fuel Malaysian Edtech startup ReSkills’ SEA expansion

Related Posts

Avanade
Current News

Avanade recognised as a Top Employer 2023 in Malaysia and Singapore

17 Jan 2023
FedEx, Managing Director of FedEx Express Malaysia, Tien Long woon
Current News

FedEx Highlights Growth Opportunities for Businesses through Regional Comprehensive Economic Partnership

13 Jan 2023
Current News

PM Anwar claims that the increase of electricity tariff is primarily for MNCs and not for local customers

14 Dec 2022

Discussion about this post

MOST POPULAR

  • The 12th International Conference on Financial Crime and Terrorism Financing (IFCTF) 2022 saw Bank Negara Malaysia's (BNM) governor talk about the ringgit's status.

    Malaysian ringgit ranked as cheapest currency in region

    0 shares
    Share 0 Tweet 0
  • Government of Sharjah Honours Partners With NFT Plaque Using SBT Technology for their Support at GITEX Global 2022, becomes world’s first to do so

    0 shares
    Share 0 Tweet 0
  • Communicators Make Historic Strides in C-suite Impact

    0 shares
    Share 0 Tweet 0
  • Kenanga Research foresees slow 5G adoption

    0 shares
    Share 0 Tweet 0
  • Malaysia’s future growth plans in ASEAN’s digital economy – MGBF

    0 shares
    Share 0 Tweet 0

MEMBERSHIP SUBSCRIPTION

Subscribe Now

Sign Up for Our Free Newsletters

Stay up-to-date with the latest personal wealth-related articles, breaking financial market news, and more.

Follow us on Social Media

News
Special Feature
Compass
Money Tube
Smart Lifestyle
Corporate Profile
Advertise
Subscriptions
Career
Contact Us
eLearning
Events
Privacy Policy
Terms of Use
Strategic Partners

Copyright © . Money Compass. All Rights Reserved.

Design and Development by Ant Internet Sdn Bhd

No Result
View All Result
  • HOME
  • NEWS
    • Global Market News
    • Local Market News
    • Corporate News
    • PLC News
  • SPECIAL FEATURE
  • COMPASS
    • Financial
    • Investment
    • Start Up
    • Capital
    • Infographics & Quotes
  • MONEY TUBE
  • LIFESTYLE
  • PR NEWSWIRE

© 2020 Money Compass

Career

SUBSCRIBE FREE NEWSLETTER